𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcome of poor prognostic phenotype non-Hodgkin’s lymphoma treatment in relation to human immunodeficiency virus serostatus

✍ Scribed by N. Anthony Othieno Abinya; G. Wanjiru Kiarie; H. Otieno Abwao; Y. Bill Mlombe; R. Omollo

Book ID
107665318
Publisher
Springer-Verlag
Year
2009
Tongue
French
Weight
113 KB
Volume
1
Category
Article
ISSN
1965-0817

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The International Prognostic Index can b
The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus—related systemic non-Hodgkin lymphoma
✍ Giuseppe Rossi; Alessandra Donisi; Salvatore Casari; Alessandro Re; GianPiero Ca 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 3 views

## BACKGROUND. The International Prognostic Index (IPI) effectively separates aggressive lymphomas into four groups with significantly different responses to therapy and survival. The authors have applied the IPI to evaluate a series of patients with human immunodeficiency virus (HIV) related lymp

Second-line chemotherapy in human immuno
Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: Evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients
✍ Umberto Tirelli; Domenico Errante; Michele Spina; Roberta Gastaldi; Ezio Nigra; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

## BACKGROUND. There is very little experience reported in the literature on the treatment of patients with relapsed or resistant human immunodeficiency virus-related non-Hodgkin's lymphoma (HIV-NIIL). We performed a prospective study to ovaluate the feasibility and activity of a second-line chemo